Bioluminescence is a striking feature of many dinoflagellates, yet the origin of the luciferin substrate that underlies light emission remains unresolved. Previous studies have noted that luciferin is structurally similar to chlorophyll and related catabolites, but its presence in heterotrophs is puzzling, as such organisms have no need to produce chlorophyll. Hypothetical and sometimes conflicting views on several luciferin biosynthesis reactions have been proposed, but a conclusive template for the pathway is missing. Here, we integrate existing evidence into a model for luciferin biosynthesis based on three testable hypotheses. First, we posit that phototrophic and heterotrophic dinoflagellates are capable of de novo luciferin synthesis through a plastid-derived pathway. Secondly, we surmise that luciferin is derived from a specific pathway for chlorophyll degradation that includes the structurally similar pyropheophorbide a. Finally, we revisit the role of P630 as a likely biosynthetic precursor rather than a mere oxidation artefact. We then outline experimental strategies to test these hypotheses within the broader framework of tetrapyrrole metabolism. Resolving luciferin biosynthesis will elucidate not only the biochemical, spatial, and regulatory underpinning of bioluminescence but also illuminate its evolutionary origins and how ancestral metabolic pathways can be retooled for novel cellular functions.
No takes yet. Share an insight, caveat, or question.
Vanstone et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: